新型抗凝药物治疗的安全性监测

新型抗凝药物治疗的安全性监测

作者：彭萍安， 秦明照

作者单位：首都医科大学附属北京同仁医院干部医疗科,北京,100730

刊名：

中国医药导刊

英文刊名：CHINESE JOURNAL OF MEDICAL GUIDE

年，卷(期)：2011,13(2)

1.Savi P.Chong BH.Greinacher A Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies:a blinded comparative multicenter study with unfractionated heparin[外文期刊] 2005

2.Warkentin TE.Cook RJ.Marder VJ Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin[外文期刊] 2005

3.Schiele F Fondaparinux and acute coronary syndromes:update on the OASIS 5-6 studies 2010

4.Smogorzewska A.Brandt JT.Chandler WL Effect of Fondaparinux on Coagulation Assays:Results of College of American Pathologists Proficiency esting 2006

5.Calatzis A.Peetz D.Haas S Prothrombinase-Induced Clotting Time Assay for Determination of the Anticoagulant Effects of Unfractionated and Low-Molecular-Weight Heparins,Fondaparinux,and Thrombin Inhibitors[外文期刊] 2008(3)

6.Mega JL.Braunwald E.Mohanavelu S Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46):a randomised,double-blind,phase II trial 2009

7.Turpie ssen ML.Davidson BL Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4):a randomised trial[外文期刊] 2009(9676)

8.Kubitza D.Becka M.Mueck W Safety,tolerability,pharmacodynamics,and pharmacokinetics of rivaroxaban-an oral,direct Factor Xa inhibitor-are not affected by aspirin 2006

9.Lindhoff-Last E.Samama MM.Ortel TL Assays for Measuring Rivaroxaban:Their Suitability and Limitations[外文期刊] 2010

10.Samama MM.Le Flem L.Guinet C Effects of rivaroxaban,a novel,oral,direct Factor Xa inhibitor,on coagulation assays[外文期刊] 2009(4)

11.Samama M.Amiral J.Guinet C Specific and rapid measurement of rivaroxaban in plasma using a new,dedicated chromogenic assay 2010

12.Dager WE.White RH Pharmacotherapy of heparin-induced thrombocytopenia[外文期刊] 2003

13.Eriksson BI.Dahl OE.Rosencher N Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement:a randomised,double-blind,non-inferiority trial[外文期刊] 2007

14.Gjin N.Stefanie S.Dritan K Bleeding After Percutaneous Coronary Intervention With Bivalirudin or Unfractionated Heparin and One-Year Mortality 2010

15.Greinacher A.Eichler P.Lubenow N Heparin-induced thrombocytopenia with thromboembolic complications:meta-analysis 2 prospective trials to assess the value of parenteral treatment with lepirudin an its therapeutic aPTT range 2000

16.Stangier J.Rathgen K.Stahle H The pharmacokinetics,pharmacodynamics and tolerability of dabigatran etexilate,a new oral direct thrombin inhibitor,in healthy male subjects[外文期刊] 2007(3)

17.Eriksson BI.Quinlan DJ.Weitz JI Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor Xa inhibitors in development[外文期刊] 2009(1)

18.Robert CG.William ED.Jeffrey HK Effect of Direct Thrombin Inhibitors,Bivalirudin,Lepirudin,and Argatroban,on Prothrombin Time and INR Values 2004

19.Carroll RC.Chavez JJ.Simmons JW Measurement of Patients' Bivalirudin Plasma Levels by a Thrombelastograph? Ecarin Clotting Time Assay:A Comparison to a Standard Activated Clotting Time[外文期刊] 2006

1.汪明杰皮下注射低分子肝素钠不同进针方法对皮下瘀斑的影响[期刊论文]-齐齐哈尔医学院学报2008,29(7)

2.李美丽低分子肝素钠的安全注射方法[期刊论文]-包头医学院学报2011,27(3)